And inhibiting EZH2 can restore the cytolytic function of CD8+CD38high T cells, which may provide promise to overcome the incidence of infections in SLE patients (Chakraborty and Mehrotra, 2020). The gene discussed is EZH2; the disease is systemic lupus erythematosus.